Zinc and Inflammatory Bowel Disease: From Clinical Study to Animal Experiment

Authors:
Publisher website
Google Scholar
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract (GI) with a high incidence rate globally, and IBD patients are often accompanied by zinc deficiency. This review aims to summarize the potential therapeutic value of zinc supplementation in IBD clinical patients and animal models. Zinc supplementation can relieve the severity of IBD especially in patients with zinc deficiency. The clinical severity of IBD were mainly evaluated through some scoring methods involving clinical performance, endoscopic observation, blood biochemistry, and pathologic biopsy. Through conducting animal experiments, it has been found that zinc plays an important role in alleviating clinical symptoms and improving pathological lesions. In both clinical observation and animal experiment of IBD, the therapeutic mechanisms of zinc interventions have been found to be related to immunomodulation, intestinal epithelial repair, and gut microbiota’s balance. Furthermore, the antioxidant activity of zinc was clarified in animal experiment. Appropriate zinc supplementation is beneficial for IBD therapy, and the present evidence highlights that alleviating zinc-deficient status can effectively improve the severity of clinical symptoms in IBD patients and animal models.
Funding Information
  • Chengdu University (2081921001)
  • Training Program for Innovation and Entrepreneurship of Chengdu University (CDUCX2024759)
  • National Natural Science Foundation of China (32370557)
  • Nanchong Key Laboratory of Wildlife Nutrition Ecology and Disease Control (NCKL202201)

This publication has 125 references indexed in Scilit: